Article info

Download PDFPDF
Systematic Review and meta-analysis
Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo
  1. Correspondence to: Felix S F Ram
    School of Health and Social Sciences, Massey University, Private Bag 102–904, North Shore, Auckland 0630, New Zealand; fsfram{at}yahoo.co.uk
View Full Text

Citation

Ram FSF
Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo

Publication history

  • First published September 21, 2011.
Online issue publication 
November 20, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.